Free Trial

New Age Alpha Advisors LLC Decreases Stock Holdings in Colgate-Palmolive Company (NYSE:CL)

Colgate-Palmolive logo with Consumer Staples background

Key Points

  • New Age Alpha Advisors LLC cut its position in Colgate-Palmolive Company by 55.7% during the first quarter, now holding 45,507 shares worth approximately $4.26 million.
  • Colgate-Palmolive reported a 12-month low of $82.40 and a high of $109.30, with a current market cap of $67.15 billion and a price-to-earnings ratio of 23.34.
  • The company is set to pay a quarterly dividend of $0.52 on August 15th, resulting in an annualized dividend of $2.08 and a yield of 2.5%.
  • Looking to Export and Analyze Colgate-Palmolive Data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

New Age Alpha Advisors LLC lessened its holdings in shares of Colgate-Palmolive Company (NYSE:CL - Free Report) by 55.7% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 45,507 shares of the company's stock after selling 57,309 shares during the quarter. New Age Alpha Advisors LLC's holdings in Colgate-Palmolive were worth $4,264,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of CL. Personal CFO Solutions LLC purchased a new position in Colgate-Palmolive during the 1st quarter worth $285,000. Vision Capital Management Inc. purchased a new position in Colgate-Palmolive during the 1st quarter worth $322,000. Autumn Glory Partners LLC boosted its holdings in Colgate-Palmolive by 67.4% during the 1st quarter. Autumn Glory Partners LLC now owns 8,905 shares of the company's stock worth $851,000 after acquiring an additional 3,586 shares during the last quarter. Financial Gravity Asset Management Inc. purchased a new position in Colgate-Palmolive during the 1st quarter worth $2,166,000. Finally, Summit Investment Advisors Inc. boosted its holdings in shares of Colgate-Palmolive by 10.8% in the 4th quarter. Summit Investment Advisors Inc. now owns 32,710 shares of the company's stock worth $2,974,000 after buying an additional 3,187 shares during the last quarter. Institutional investors own 80.41% of the company's stock.

Colgate-Palmolive Price Performance

CL traded down $0.00 during midday trading on Friday, hitting $84.71. The stock had a trading volume of 4,133,894 shares, compared to its average volume of 4,850,591. The company has a market cap of $68.46 billion, a P/E ratio of 23.79, a price-to-earnings-growth ratio of 4.41 and a beta of 0.35. The business has a fifty day moving average of $88.92 and a 200 day moving average of $90.15. The company has a debt-to-equity ratio of 6.79, a quick ratio of 0.28 and a current ratio of 0.89. Colgate-Palmolive Company has a 1 year low of $82.40 and a 1 year high of $109.30.

Colgate-Palmolive (NYSE:CL - Get Free Report) last released its quarterly earnings data on Friday, August 1st. The company reported $0.92 earnings per share for the quarter, beating analysts' consensus estimates of $0.89 by $0.03. The firm had revenue of $5.11 billion during the quarter, compared to analyst estimates of $5.03 billion. Colgate-Palmolive had a return on equity of 377.63% and a net margin of 14.55%. The business's quarterly revenue was up 1.0% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.91 earnings per share. As a group, equities analysts forecast that Colgate-Palmolive Company will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 15th. Shareholders of record on Friday, July 18th will be issued a $0.52 dividend. The ex-dividend date is Friday, July 18th. This represents a $2.08 dividend on an annualized basis and a yield of 2.5%. Colgate-Palmolive's dividend payout ratio is 58.43%.

Wall Street Analyst Weigh In

CL has been the topic of a number of research reports. UBS Group lowered their price objective on Colgate-Palmolive from $109.00 to $106.00 and set a "buy" rating on the stock in a research note on Thursday, July 17th. Barclays boosted their price objective on Colgate-Palmolive from $86.00 to $87.00 and gave the company an "equal weight" rating in a research note on Tuesday, July 15th. JPMorgan Chase & Co. reduced their price objective on shares of Colgate-Palmolive from $99.00 to $95.00 and set an "overweight" rating for the company in a research note on Monday. Wall Street Zen cut shares of Colgate-Palmolive from a "buy" rating to a "hold" rating in a research note on Wednesday, May 7th. Finally, Morgan Stanley set a $96.00 price target on shares of Colgate-Palmolive and gave the company an "overweight" rating in a research report on Monday. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and seven have assigned a buy rating to the company's stock. According to data from MarketBeat, the stock has an average rating of "Hold" and a consensus price target of $98.92.

Read Our Latest Research Report on Colgate-Palmolive

Colgate-Palmolive Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

See Also

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Should You Invest $1,000 in Colgate-Palmolive Right Now?

Before you consider Colgate-Palmolive, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.

While Colgate-Palmolive currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Buy-the-Dip Stocks Poised to Rebound Soon
Quantum Boom: 3 Strong Picks with Lower Risk
3 Overlooked AI Stocks That Chipmakers Can’t Live Without

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines